A silver-catalyzed formal [3 + 3] annulation of 3-methyleneisoindolin-1-one with alkynol for the synthesis of 1,5-dihydroindolizin-3(2)-one derivatives is disclosed. The protocol allows practical synthesis of -heterocyclic scaffolds with a broad scope of functional groups and could be efficiently scaled up to gram scale, which incarnates a potential application of this methodology. In addition, a range of chlorine anion substitution of alkenes can be constructed by adjusting the structure of the alkynol substrates with the use of TMSCl.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.joc.9b02533DOI Listing

Publication Analysis

Top Keywords

silver trifluoromethanesulfonate-catalyzed
4
trifluoromethanesulfonate-catalyzed annulation
4
annulation propargylic
4
propargylic alcohols
4
alcohols 3-methyleneisoindolin-1-one
4
3-methyleneisoindolin-1-one silver-catalyzed
4
silver-catalyzed formal
4
formal annulation
4
annulation 3-methyleneisoindolin-1-one
4
3-methyleneisoindolin-1-one alkynol
4

Similar Publications

A silver-catalyzed formal [3 + 3] annulation of 3-methyleneisoindolin-1-one with alkynol for the synthesis of 1,5-dihydroindolizin-3(2)-one derivatives is disclosed. The protocol allows practical synthesis of -heterocyclic scaffolds with a broad scope of functional groups and could be efficiently scaled up to gram scale, which incarnates a potential application of this methodology. In addition, a range of chlorine anion substitution of alkenes can be constructed by adjusting the structure of the alkynol substrates with the use of TMSCl.

View Article and Find Full Text PDF

Synthesis and antitumor activity of novel 4-demethoxyanthracyclines.

J Med Chem

September 1990

Roche Products Limited, Welwyn Garden City, Hertfordshire, England.

A versatile and efficient synthetic route to 4-demethoxyanthracyclinones has been utilized in the preparation of a number of aglycons having 9-alkyl, 9-(hydroxylalkyl), or 9-carbamoyl substituents. Silver trifluoromethanesulfonate catalyzed coupling of these aglycons with various daunosamine derivatives has yielded a series of novel anthracyclines which have been evaluated as antitumor agents. 9-Alkylanthracyclines 22, 23, 33, and 34 have higher efficacy vs L-1210 leukemia than the parent 4-demethoxydaunorubicin (21), or the natural anthracyclines daunorubicin (1) and doxorubicin (2).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!